Fighting Microbes with Microbes

  • Boopathi Seenivasan
  • Chiranth M. Prakash
  • Vani JanakiramanEmail author


Microbes exhibit a strong association with human beings by colonizing different parts of the body. These microbes can be either beneficial or harmful. Pathogenic microbes are known to cause serious infections in humans and in other multicellular organisms which disturb the host physiology. These pathogenic microbes have intrinsic traits which contribute to their survival under hostile conditions, evasion of host immune responses and resistance to various therapeutic agents which in turn confers them with near invincibility. Therefore, exploration of novel agents which could specifically target and kill microbes is very much on the demand. Interestingly, one such agent could be microbes themselves. Utilizing microbial components and/or microbial whole cells either to target pathogens directly or at modulating the biological fitness of the host including boosting host immune responses. In this chapter, we discuss these various modes by which microbes and their products could be employed in combating microbial infections, eventually to improve healthcare.


Bacteria Gut flora Commensal Faecal microbial transplantation 


  1. Ahmad V, Khan MS, Jamal QMS, Alzohairy MA, Al Karaawi MA, Siddiqui MU (2017) Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. Int J Antimicrob Agents 49(1):1–11PubMedGoogle Scholar
  2. Altamirano FLG, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev 32(2):e00066–e00018Google Scholar
  3. Bassler BL (2002) Small talk: cell-to-cell communication in bacteria. Cell 109(4):421–424PubMedGoogle Scholar
  4. Benz J, Meinhart A (2014) Antibacterial effector/immunity systems: it’s just the tip of the iceberg. Curr Opin Microbiol 17:1–10PubMedGoogle Scholar
  5. Birri DJ, Brede DA, Nes IF (2012) Salivaricin D, a novel intrinsically trypsin-resistant antibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl Environ Microbiol 78(2):402–410PubMedPubMedCentralGoogle Scholar
  6. Bolmstedt AJ, O’Keefe BR, Shenoy SR, McMahon JB, Boyd MR (2001) Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol Pharmacol 59(5):949–954PubMedGoogle Scholar
  7. Boopathi S, Vashisth R, Manoharan P, Kandasamy R, Sivakumar N (2017) Stigmatellin Y–an anti-biofilm compound from Bacillus subtilis BR4 possibly interferes in PQS–PqsR mediated quorum sensing system in Pseudomonas aeruginosa. Bioorg Med Chem Lett 27(10):2113–2118PubMedGoogle Scholar
  8. Borody TJ, Warren EF, Leis S, Surace R, Ashman O (2003) Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37(1):42–47PubMedGoogle Scholar
  9. Borysowski J, Weber-Dąbrowska B, Górski A (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 231(4):366–377Google Scholar
  10. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517(7533):205PubMedGoogle Scholar
  11. Chan BK, Abedon ST, Loc-Carrillo C (2013) Phage cocktails and the future of phage therapy. Future Microbiol 8(6):769–783PubMedGoogle Scholar
  12. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148(6):1258–1270PubMedPubMedCentralGoogle Scholar
  13. Cohen LJ, Han S, Huang YH, Brady SF (2017) Identification of the colicin V bacteriocin gene cluster by functional screening of a human microbiome metagenomic library. ACS infect Dis 4(1):27–32PubMedPubMedCentralGoogle Scholar
  14. Cornick S, Tawiah A, Chadee K (2015) Roles and regulation of the mucus barrier in the gut. Tissue Barriers 3(1–2):e982426PubMedPubMedCentralGoogle Scholar
  15. Cotter PD, Ross RP, Hill C (2013) Bacteriocins—a viable alternative to antibiotics? Nat Rev Microbiol 11(2):95PubMedPubMedCentralGoogle Scholar
  16. Dashiff A, Junka RA, Libera M, Kadouri DE (2011) Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. J Appl Microbiol 110(2):431–444PubMedGoogle Scholar
  17. De Kraker ME, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 13(11):e1002184PubMedPubMedCentralGoogle Scholar
  18. De Leon LM, Watson JB, Kelly CR (2013) Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 11(8):1036–1038PubMedGoogle Scholar
  19. Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K et al (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25(5):730PubMedPubMedCentralGoogle Scholar
  20. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H et al (2013) Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14(1):26–37PubMedPubMedCentralGoogle Scholar
  21. Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O’leary CE et al (2014) The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 20(5):524PubMedPubMedCentralGoogle Scholar
  22. Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human–microbe mutualism and disease. Nature 449(7164):811PubMedGoogle Scholar
  23. Donia MS, Fischbach MA (2015) Small molecules from the human microbiota. Science 349(6246):1254766PubMedPubMedCentralGoogle Scholar
  24. Donia MS, Cimermancic P, Schulze CJ, Brown LCW, Martin J, Mitreva M et al (2014) A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158(6):1402–1414PubMedPubMedCentralGoogle Scholar
  25. Fachi JL, de Souza Felipe J, Pral LP, da Silva BK, Corrêa RO, de Andrade MCP et al (2019) Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism. Cell Rep 27(3):750–761PubMedGoogle Scholar
  26. Feng Q, Chen WD, Wang YD (2018) Gut microbiota: an integral moderator in health and disease. Front Microbiol 9:151PubMedPubMedCentralGoogle Scholar
  27. Gervasi T, Horn N, Wegmann U, Dugo G, Narbad A, Mayer MJ (2014) Expression and delivery of an endolysin to combat Clostridium perfringens. Appl Microbiol Biotechnol 98(6):2495–2505PubMedGoogle Scholar
  28. Ghosh C, Sarkar P, Issa R, Haldar J (2019) Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol 27:323PubMedGoogle Scholar
  29. Gupta S, Tang C, Tran M, Kadouri DE (2016) Effect of predatory bacteria on human cell lines. PLoS One 11(8):e0161242PubMedPubMedCentralGoogle Scholar
  30. Hajam IA, Dar PA, Won G, Lee JH (2017) Bacterial ghosts as adjuvants: mechanisms and potential. Vet Res 48(1):37PubMedPubMedCentralGoogle Scholar
  31. Herp S, Brugiroux S, Garzetti D, Ring D, Jochum LM, Beutler M et al (2019) Mucispirillum schaedleri antagonizes Salmonella virulence to protect mice against colitis. Cell Host Microbe 25(5):681–694PubMedGoogle Scholar
  32. Hols P, Ledesma-García L, Gabant P, Mignolet J (2019) Mobilization of microbiota commensals and their bacteriocins for therapeutics. Trends Microbiol 27:690. Scholar
  33. Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10(3):159PubMedPubMedCentralGoogle Scholar
  34. Hsiao A, Ahmed AS, Subramanian S, Griffin NW, Drewry LL, Petri WA et al (2014) Members of the human gut microbiota involved in recovery from Vibrio cholerae infection. Nature 515(7527):423PubMedPubMedCentralGoogle Scholar
  35. Hughes KA, Sutherland IW, Jones MV (1998) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144(11):3039–3047PubMedGoogle Scholar
  36. Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR (2007) Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol 73(4):1107–1113PubMedGoogle Scholar
  37. Jacobs MC, Haak BW, Hugenholtz F, Wiersinga WJ (2017) Gut microbiota and host defense in critical illness. Curr Opin Crit Care 23(4):257–263PubMedGoogle Scholar
  38. Jani AJ, Cotter PA (2010) Type VI secretion: not just for pathogenesis anymore. Cell Host Microbe 8(1):2–6PubMedPubMedCentralGoogle Scholar
  39. Kadouri DE, To K, Shanks RM, Doi Y (2013) Predatory bacteria: a potential ally against multidrug-resistant Gram-negative pathogens. PLoS One 8(5):e63397PubMedPubMedCentralGoogle Scholar
  40. Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14(7):685PubMedPubMedCentralGoogle Scholar
  41. Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS et al (2019) Bile acid 7α-dehydroxylating gut bacteria secrete antibiotics that inhibit Clostridium difficile: role of secondary bile acids. Cell Chem Biol 26(1):27–34PubMedGoogle Scholar
  42. Kim Y, Lee D, Kim D, Cho J, Yang J, Chung M et al (2008) Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 31(4):468PubMedGoogle Scholar
  43. Kohli N, Crisp Z, Riordan R, Li M, Alaniz RC, Jayaraman A (2018) The microbiota metabolite indole inhibits Salmonella virulence: involvement of the PhoPQ two-component system. PLoS One 13(1):e0190613PubMedPubMedCentralGoogle Scholar
  44. Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y et al (2011) Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol 4(6):648PubMedPubMedCentralGoogle Scholar
  45. Libertucci J, Young VB (2019) The role of the microbiota in infectious diseases. Nat Microbiol 4(1):35PubMedGoogle Scholar
  46. Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8(3):162PubMedPubMedCentralGoogle Scholar
  47. Litvak Y, Mon KK, Nguyen H, Chanthavixay G, Liou M, Velazquez EM et al (2019) Commensal Enterobacteriaceae protect against Salmonella colonization through oxygen competition. Cell Host Microbe 25(1):128–139PubMedGoogle Scholar
  48. Lu TK, Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci 104(27):11197–11202PubMedGoogle Scholar
  49. Lu TK, Collins JJ (2009) Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci 106(12):4629–4634PubMedGoogle Scholar
  50. Lubitz P, Mayr UB, Lubitz W (2009) Applications of bacterial ghosts in biomedicine, Pharmaceutical biotechnology. Springer, New York, pp 159–170Google Scholar
  51. Lukáš F, Gorenc G, Kopečný J (2008) Detection of possible AI-2-mediated quorum sensing system in commensal intestinal bacteria. Folia Microbiol 53(3):221–224Google Scholar
  52. Maltby R, Leatham-Jensen MP, Gibson T, Cohen PS, Conway T (2013) Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157: H7 in the mouse intestine. PloS one 8(1):e53957PubMedPubMedCentralGoogle Scholar
  53. Momose Y, Hirayama K, Itoh K (2008) Competition for proline between indigenous Escherichia coli and E. coli O157: H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157: H7. Antonie Van Leeuwenhoek 94(2):165–171PubMedGoogle Scholar
  54. Monnappa AK, Bari W, Choi SY, Mitchell RJ (2016) Investigating the responses of human epithelial cells to predatory bacteria. Sci Rep 6:33485PubMedPubMedCentralGoogle Scholar
  55. Natividad JM, Hayes CL, Motta JP, Jury J, Galipeau HJ, Philip V et al (2013) Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. Appl Environ Microbiol 79(24):7745–7754PubMedPubMedCentralGoogle Scholar
  56. Negus D, Moore C, Baker M, Raghunathan D, Tyson J, Sockett RE (2017) Predator versus pathogen: how does predatory Bdellovibrio bacteriovorus interface with the challenges of killing gram-negative pathogens in a host setting? Annu Rev Microbiol 71:441–457PubMedGoogle Scholar
  57. Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA (2001) Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 69(3):1329–1336PubMedPubMedCentralGoogle Scholar
  58. Oh S, Go GW, Mylonakis E, Kim Y (2012) The bacterial signalling molecule indole attenuates the virulence of the fungal pathogen Candida albicans. J Appl Microbiol 113(3):622–628PubMedGoogle Scholar
  59. O’Toole RF, Gautam SS (2018) The host microbiome and impact of tuberculosis chemotherapy. Tuberculosis 113:26–29PubMedGoogle Scholar
  60. Paharik AE, Parlet CP, Chung N, Todd DA, Rodriguez EI, Van Dyke MJ et al (2017) Coagulase-negative staphylococcal strain prevents Staphylococcus aureus colonization and skin infection by blocking quorum sensing. Cell Host Microbe 22(6):746–756PubMedPubMedCentralGoogle Scholar
  61. Park H, Yeo S, Ji Y, Lee J, Yang J, Park S et al (2014) Autoinducer-2 associated inhibition by Lactobacillus sakei NR28 reduces virulence of enterohaemorrhagic Escherichia coli O157: H7. Food Control 45:62–69Google Scholar
  62. Pickard JM, Zeng MY, Caruso R, Núñez G (2017) Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279(1):70–89PubMedPubMedCentralGoogle Scholar
  63. Pujol A, Crost EH, Simon G, Barbe V, Vallenet D, Gomez A, Fons M (2011) Characterization and distribution of the gene cluster encoding RumC, an anti-Clostridium perfringens bacteriocin produced in the gut. FEMS Microbiol Ecol 78(2):405–415PubMedGoogle Scholar
  64. Russell AB, Peterson SB, Mougous JD (2014a) Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol 12(2):137PubMedPubMedCentralGoogle Scholar
  65. Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, Goo YA et al (2014b) A type VI secretion-related pathway in Bacteroidetes mediates interbacterial antagonism. Cell Host Microbe 16(2):227–236PubMedPubMedCentralGoogle Scholar
  66. Salomon RA, Farías RN (1992) Microcin 25, a novel antimicrobial peptide produced by Escherichia coli. J Bacteriol 174(22):7428–7435Google Scholar
  67. Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD et al (2016) The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65(4):575–583PubMedGoogle Scholar
  68. Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F et al (2019) The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50(2):432–445PubMedPubMedCentralGoogle Scholar
  69. Secchi M, Xu Q, Lusso P, Vangelista L (2009) The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. Protein Expr Purif 68(1):34–41PubMedPubMedCentralGoogle Scholar
  70. Skelly AN, Sato Y, Kearney S, Honda K (2019) Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 19:1Google Scholar
  71. Sommer F, Bäckhed F (2013) The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11(4):227PubMedGoogle Scholar
  72. Sorg JA, Sonenshein AL (2008) Bile salts and glycine as co germinants for Clostridium difficile spores. J Bacteriol 190(7):2505–2512PubMedPubMedCentralGoogle Scholar
  73. Thompson JA, Oliveira RA, Djukovic A, Ubeda C, Xavier KB (2015) Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. Cell Rep 10(11):1861–1871PubMedGoogle Scholar
  74. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature 449(7164):804PubMedPubMedCentralGoogle Scholar
  75. Vancamelbeke M, Vermeire S (2017) The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol 11(9):821–834PubMedPubMedCentralGoogle Scholar
  76. Vieira AT, Rocha VM, Tavares L, Garcia CC, Teixeira MM, Oliveira SC et al (2016) Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A. Microbes Infect 18(3):180–189PubMedGoogle Scholar
  77. Waters CM, Bassler BL (2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 21:319–346PubMedGoogle Scholar
  78. Zipperer A, Konnerth MC, Laux C, Berscheid A, Janek D, Weidenmaier C et al (2016) Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535(7613):511PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Boopathi Seenivasan
    • 1
  • Chiranth M. Prakash
    • 1
  • Vani Janakiraman
    • 1
    Email author
  1. 1.Department of Biotechnology, Bhupat and Jyoti Mehta School of BiosciencesIndian Institute of Technology MadrasChennaiIndia

Personalised recommendations